Abstract Details

Title Sample Size Calculations for a Parallel Groups, Placebo Controlled Treatment Trial in Secondary Progressive Multiple Sclerosis Using Cerebral Atrophy as the Primary Outcome Measure

Topic

Presentation(s)

Poster/Presentation
Number 002

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Ahmad El Kouzi, MD, FAAN	Dr. El Kouzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Michelle Whaley (Swedish Medical Center)	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Maria C. Rodriquez (Clinica Quiron)	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��